b.imune - your immune system, supported from the inside out.

In stock
Regular price
€59,00
Sale price
€59,00
Regular price
€59,00
Free shipping
Plan duration
Plan duration: 30 Days Plan
✨ Unique formula

Immune-focused probiotic with vitamin D3 and a high dose of β-glucans from yeast to support year-round defences.

🧬 Scientifically developed

Built around Lacticaseibacillus rhamnosus CRL 1505 – a strain studied in more than 35 preclinical and clinical trials for immune function.

🌱 Clean composition

Suitable for vegans, people with histamine intolerance and those following gluten-free, keto or intermittent fasting regimes. Capsules can be opened and mixed into a drink.

 

What it does

  • Supports the normal function of the immune system, with 800 IU plant-derived vitamin D3 per daily dose.
  • Helps the body’s natural defence against respiratory and intestinal infections – especially useful for people who fall ill frequently.
  • Provides 450 mg yeast β-glucans to modulate immune responses and nourish beneficial gut bacteria.
  • Resistant to stomach acid and bile, so the bacteria reach the intestine in active form.

 

Why it matters

CRL 1505 has been shown to increase resistance to respiratory and intestinal infections, including in a large study of nearly 300 children.
Vitamin D3 contributes to normal immune function, yet deficiency is widespread across Europe – making adequate daily intake especially important.

Yeast β-glucans with long molecular chains and high bioavailability can stimulate gut-associated immune cells, activate macrophages and provide antioxidant support, acting as both microbiome fuel and immune modulator

 

Ingredients (per daily dose - 2 capsules):

Lacticaseibacillus rhamnosus CRL1505 – 1 x 10⁹ CFU

(1,3)-(1,6)-β-D-glucan – 450 mg

Vitamin D3 (plant-derived cholecalciferol) – 20 µg (800 IU) – 133% NRV

 

Package leaflet

MVDr. Alojz Bomba, DrSc.

At the heart of Beie.’s innovation stands MVDr. Alojz Bomba, DrSc., co-founder and Chief Scientific Officer of PerBiotiX, and former head of Experimental Medicine at Pavol J. Šafárik University in Košice. With over 40 years of microbiome research, he pioneered the concept of targeted modulation of gut microbiota—a methodology now published and cited internationally. Prof. Bomba led major EU-funded projects studying probiotic and bioactive substances aimed at preventing conditions such as inflammatory bowel diseases, cancer, allergies, and metabolic disorders. He’s also the founder of the International Probiotics & Prebiotics Conference—one of the largest global gatherings of microbiome scientists.